Literature DB >> 1969524

Fluoroquinolone resistance in Campylobacter spp isolated from human stools and poultry products.

H P Endtz, R P Mouton, T van der Reyden, G J Ruijs, M Biever, B van Klingeren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1969524     DOI： 10.1016/0140-6736(90)90897-e

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

Review 1.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

2.  Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998.

Authors:  Y Sáenz; M Zarazaga; M Lantero; M J Gastanares; F Baquero; C Torres
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Characterization of high-level quinolone resistance in Campylobacter jejuni.

Authors:  T D Gootz; B A Martin
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 4.  Infectious diarrhoea.

Authors:  C P Conlon; T E Peto
Journal:  Int J Colorectal Dis       Date:  1990-12       Impact factor: 2.571

5.  Prevalence and antibiotic susceptibility of thermophilic Campylobacter isolates from free range domestic duck (Cairina moschata) in Morogoro municipality, Tanzania.

Authors:  Hezron Emmanuel Nonga; A P Muhairwa
Journal:  Trop Anim Health Prod       Date:  2009-06-28       Impact factor: 1.559

Review 6.  Fluoroquinolones: use of clinical data to aid formulary choice by the system of objective judgement analysis (SOJA) method.

Authors:  R Janknegt
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

7.  Increased resistance of enteropathogens to fluoroquinolones in Barcelona, Spain.

Authors:  F Navarro; E Miró; C Izquierdo; B Mirelis; G Prats
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

8.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

9.  Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients.

Authors:  J Reina; M J Ros; A Serra
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

10.  Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin.

Authors:  H Adler-Mosca; J Lüthy-Hottenstein; G Martinetti Lucchini; A Burnens; M Altwegg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.